Baird Medical Investment (BDMD) vs Sonoma Pharmaceuticals (SNOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Baird Medical Investment is the larger company by market cap ($5.1 million vs $3.7 million), about 1.4 times the size, while Sonoma Pharmaceuticals is growing revenue faster (+36.7% vs -39.2%). Sonoma Pharmaceuticals converts more of its revenue into profit, with a net margin of -16.3% versus -121.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDMD | SNOA |
|---|---|---|
| Share price | $0.0897 | $0.722 |
| Market cap | $5.07M | $3.65M |
| 1-day change | -12.91% | -10.83% |
| YTD return | -93.40% | — |
| 1-year return | -93.64% | — |
| Forward P/E | 0.64 | — |
| EPS (TTM) | $-0.55 | $-0.90 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $22.54M | $19.53M |
| Revenue growth (YoY) | -39.15% | +36.68% |
| Net income (latest FY) | $-27.28M | $-3.17M |
| Gross margin | 83.79% | 37.97% |
| Operating margin | -113.73% | -12.60% |
| Net margin | -121.04% | -16.26% |
| 52-week high | $3.70 | $3.95 |
| 52-week low | $0.073 | $0.72 |
| Distance from 52-week high | -97.58% | -81.72% |
| Analyst consensus | none | — |
| Avg. price target upside | +4359.31% | — |
| Average volume | 16.31M | 61.96K |
| Shares outstanding | 56.52M | 5.06M |
| Employees | 146 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sonoma Pharmaceuticals is more profitable, keeping -16.3 cents of every revenue dollar as net income versus -121.0 cents for Baird Medical Investment.
- Sonoma Pharmaceuticals grew revenue faster in its latest fiscal year (+36.68% vs -39.15%).
About Baird Medical Investment
BDMD stock →Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.
Health Care · Medical/Dental Instruments · 146 employees
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
BDMD vs SNOA FAQ
Which is bigger, Baird Medical Investment or Sonoma Pharmaceuticals?
Baird Medical Investment (BDMD) is larger, with a market capitalization of $5.07M compared with $3.65M for Sonoma Pharmaceuticals (SNOA).
Are Baird Medical Investment and Sonoma Pharmaceuticals in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.